Growth Metrics

Orthopediatrics (KIDS) Long-Term Debt Issuances (2016 - 2024)

Orthopediatrics (KIDS) has disclosed Long-Term Debt Issuances for 5 consecutive years, with $73.5 million as the latest value for Q3 2024.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to $73.5 million in Q3 2024 year-over-year; TTM through Dec 2025 was $73.5 million, a 11.36% decrease, with the full-year FY2025 number at $25.0 million, down 66.0% from a year prior.
  • Long-Term Debt Issuances was $73.5 million for Q3 2024 at Orthopediatrics, up from $9.4 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $73.5 million in Q3 2024 to a low of -$31.0 million in Q4 2022.
  • A 3-year average of $17.3 million and a median of $9.4 million in 2023 define the central range for Long-Term Debt Issuances.
  • Biggest YoY gain for Long-Term Debt Issuances was 130.4% in 2023; the steepest drop was 130.4% in 2023.
  • Orthopediatrics' Long-Term Debt Issuances stood at -$31.0 million in 2022, then surged by 130.4% to $9.4 million in 2023, then surged by 680.27% to $73.5 million in 2024.
  • Per Business Quant, the three most recent readings for KIDS's Long-Term Debt Issuances are $73.5 million (Q3 2024), $9.4 million (Q4 2023), and -$31.0 million (Q4 2022).